Introduction of laparoscopic Ivor Lewis esophagectomy as hybrid procedure and comparison with open esophagectomy. A propensity-matched retrospective study.


Journal

Minerva surgery
ISSN: 2724-5438
Titre abrégé: Minerva Surg
Pays: Italy
ID NLM: 101777295

Informations de publication

Date de publication:
Feb 2022
Historique:
entrez: 22 3 2022
pubmed: 23 3 2022
medline: 24 3 2022
Statut: ppublish

Résumé

Esophagectomy is associated with increased rate of postoperative complications, making it one of the procedures with the highest impact on patients' quality of life. Hybrid Ivor Lewis esophagectomy (HMIE) has been introduced in our clinic with the aim to reduce postoperative morbidity, without compromising on oncological outcomes. We conducted this survey to evaluate the perioperative morbidity of the new method during the introduction phase compared to open esophagectomy in two similarly matched groups of patients. This study included the first 17 patients who underwent HMIE for esophageal cancer at a high-volume tertiary center. After generating propensity scores using the variables age, body mass index, pulmonary comorbidities, cardiac comorbidities, histologic type, and neoadjuvant treatment, 17 patients in the hybrid group were matched with 17 patients in the open group. Surgical outcomes, oncological outcomes, and postoperative complications according to the guidelines of the Esophageal Complications Consensus Group were compared between the two groups. Surgical and oncological outcomes were comparable between the two approaches. The rate of postoperative complications, including surgical, gastrointestinal, and pulmonary complications, were similar in the two groups. Our hypothesis that laparoscopy could reduce postoperative complications was not confirmed. HMIE is a safe procedure, resulting in radical oncological resection and similar morbidity with open esophagectomy. Surgeons, who are proficient in open approach and laparoscopic anti-reflux and gastric surgery, can safely adopt the hybrid approach without significant learning curve associated morbidity.

Sections du résumé

BACKGROUND BACKGROUND
Esophagectomy is associated with increased rate of postoperative complications, making it one of the procedures with the highest impact on patients' quality of life. Hybrid Ivor Lewis esophagectomy (HMIE) has been introduced in our clinic with the aim to reduce postoperative morbidity, without compromising on oncological outcomes. We conducted this survey to evaluate the perioperative morbidity of the new method during the introduction phase compared to open esophagectomy in two similarly matched groups of patients.
METHODS METHODS
This study included the first 17 patients who underwent HMIE for esophageal cancer at a high-volume tertiary center. After generating propensity scores using the variables age, body mass index, pulmonary comorbidities, cardiac comorbidities, histologic type, and neoadjuvant treatment, 17 patients in the hybrid group were matched with 17 patients in the open group. Surgical outcomes, oncological outcomes, and postoperative complications according to the guidelines of the Esophageal Complications Consensus Group were compared between the two groups.
RESULTS RESULTS
Surgical and oncological outcomes were comparable between the two approaches. The rate of postoperative complications, including surgical, gastrointestinal, and pulmonary complications, were similar in the two groups.
CONCLUSIONS CONCLUSIONS
Our hypothesis that laparoscopy could reduce postoperative complications was not confirmed. HMIE is a safe procedure, resulting in radical oncological resection and similar morbidity with open esophagectomy. Surgeons, who are proficient in open approach and laparoscopic anti-reflux and gastric surgery, can safely adopt the hybrid approach without significant learning curve associated morbidity.

Identifiants

pubmed: 35315265
pii: S2724-5691.21.08912-7
doi: 10.23736/S2724-5691.21.08912-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

Antonios E Spiliotis (AE)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany - antonios.spiliotis@uks.eu.

Gereon Gäbelein (G)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany.

Maciej Malinowski (M)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany.

Sebastian Holländer (S)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany.

Philipp-Robert Scherber (PR)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany.

Matthias Glanemann (M)

Department of General, Visceral, Vascular and Pediatric Surgery, University Clinic of Saarland, Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH